Market Tracker

07/03 4:45pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

16.75
Delayed Data
As of Jul 02
 -0.21 / -1.24%
Today’s Change
7.31
Today|||52-Week Range
18.55
+101.81%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close16.96
Today’s open17.01
Day’s range16.67 - 17.05
Volume534,187
Average volume (3 months)1,049,764
Market cap$800.0M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-51.56%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio23.8
Price/Sales3.44
Price/Book10.09

Competitors

 Today’s
change
Today’s
% change
SGNTSagent Pharmaceutica...+0.49+1.99%
ENTAEnanta Pharmaceutica...-1.74-3.87%
COCPCocrystal Pharma Inc0.000.00%
AMPHAmphastar Pharmaceut...-0.26-1.49%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.02
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts